Clinical Trial Update: Characterization of the Changes in the Signalling Pathways During Spinal Cord Injury-induced Skeletal Muscle Atrophy [NA]

View source ↗

Summary

This clinical trial update describes the characterization of signaling pathway changes during skeletal muscle atrophy caused by spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skeletal Muscle Atrophy
• Spinal Cord Injury

Snippet

Sponsor: Clinique Romande de Readaptation | Conditions: Spinal Cord Injuries, Muscle Atrophy | NA | Status: UNKNOWN